FDA approves cannabis-derived medicine; DEA must weigh in
The U.S. Food and Drug Administration has approved a CBD drug - a landmark decision that will trigger…
News June 25
Latest In: GW Pharmaceuticals
Major UK review could lead to medical marijuana legalization
The United Kingdom is embarking on a full review of the medical benefits of cannabis that experts say could…
News June 19
FDA advisory panel gives thumbs-up to CBD epilepsy treatment
A CBD treatment for epilepsy is closer to becoming the first cannabis medicine approved for the U.S. market.
News April 19
Here’s how the FDA’s review of epilepsy drug could affect CBD companies
It’s shaping up to be a watershed summer for the cannabis industry with the U.S. Food and Drug…
News April 18
Latin America Update: Marijuana business developments in Chile and Argentina
While Canada and the United States dominated marijuana headlines over the past year, their neighbors in Latin America…
News February 14
GW Pharma aiming for FDA approval for CBD drug this year, again
British cannabis company GW Pharmaceuticals is hoping the U.S. Food and Drug Administration will sign off on its…
News January 26GW Pharma plans to expand marijuana operations in UK
One of the world’s biggest marijuanas companies – GW Phamaceuticals – is poised to get even bigger. The…
News August 29
Brazil allows sale of cannabis-based MS drug
Brazil’s health care regulator, ANVISA, handed out the nation’s first license for the sale of a cannabis-based drug…
News January 18GW Pharma scuttles UK listing to trade on U.S. market
GW Pharmaceuticals, a high-flying biotech firm in the United Kingdom that is seeking U.S. regulatory approval for a…
News October 19Featured
1
Latest Sponsored
